These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33162994)

  • 1. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
    Front Immunol; 2020; 11():579000. PubMed ID: 33162994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
    Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
    FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice.
    Mancuso R; Fryatt G; Cleal M; Obst J; Pipi E; Monzón-Sandoval J; Ribe E; Winchester L; Webber C; Nevado A; Jacobs T; Austin N; Theunis C; Grauwen K; Daniela Ruiz E; Mudher A; Vicente-Rodriguez M; Parker CA; Simmons C; Cash D; Richardson J; ; Jones DNC; Lovestone S; Gómez-Nicola D; Perry VH
    Brain; 2019 Oct; 142(10):3243-3264. PubMed ID: 31504240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Regulation of Microglial Activation in Response to Different Degree of Ischemia.
    Gao H; Ju F; Ti R; Zhang Y; Zhang S
    Front Immunol; 2022; 13():792638. PubMed ID: 35154109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries.
    Pons V; Laflamme N; Préfontaine P; Rivest S
    Front Immunol; 2020; 11():47. PubMed ID: 32082318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced M-CSF/CSF1R Signaling Closely Associates with PrP
    Xia Y; Chen C; Chen J; Hu C; Yang W; Wang L; Liu L; Gao LP; Wu YZ; Chen DD; Shi Q; Chen ZB; Dong XP
    Mol Neurobiol; 2022 Oct; 59(10):6534-6551. PubMed ID: 35970974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Microglial CSF1R Expression in the SIV/Macaque Model of HIV CNS Disease.
    Knight AC; Brill SA; Queen SE; Tarwater PM; Mankowski JL
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):199-206. PubMed ID: 29319809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
    J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
    Martínez-Muriana A; Mancuso R; Francos-Quijorna I; Olmos-Alonso A; Osta R; Perry VH; Navarro X; Gomez-Nicola D; López-Vales R
    Sci Rep; 2016 May; 6():25663. PubMed ID: 27174644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF1R blockade slows progression of cerebral hemorrhage by reducing microglial proliferation and increasing infiltration of CD8 + CD122+ T cells into the brain.
    Cheng F; Wang C; Yan B; Yin Z; Liu Y; Zhang L; Li M; Liao P; Gao H; Jia Z; Li D; Liu Q; Lei P
    Int Immunopharmacol; 2024 May; 133():112071. PubMed ID: 38636374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia regulate hippocampal neurogenesis during chronic neurodegeneration.
    De Lucia C; Rinchon A; Olmos-Alonso A; Riecken K; Fehse B; Boche D; Perry VH; Gomez-Nicola D
    Brain Behav Immun; 2016 Jul; 55():179-190. PubMed ID: 26541819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition.
    Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk KC; Sortwell CE
    J Neuroinflammation; 2024 Apr; 21(1):108. PubMed ID: 38664840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.
    Rojo R; Raper A; Ozdemir DD; Lefevre L; Grabert K; Wollscheid-Lengeling E; Bradford B; Caruso M; Gazova I; Sánchez A; Lisowski ZM; Alves J; Molina-Gonzalez I; Davtyan H; Lodge RJ; Glover JD; Wallace R; Munro DAD; David E; Amit I; Miron VE; Priller J; Jenkins SJ; Hardingham GE; Blurton-Jones M; Mabbott NA; Summers KM; Hohenstein P; Hume DA; Pridans C
    Nat Commun; 2019 Jul; 10(1):3215. PubMed ID: 31324781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain.
    Zhan L; Fan L; Kodama L; Sohn PD; Wong MY; Mousa GA; Zhou Y; Li Y; Gan L
    Elife; 2020 Oct; 9():. PubMed ID: 33054973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.